Some biomarkers to monitor disease state assess severity of COVID-19 patients have been identified including IL-6, C-reactive protein (CRP), alanine aminotransferase (ALT), aspartate aminotransferase (AST) [11], plasma D-dimers [12] as well as leukocyte and lymphocyte counts [13]. This evidence concerns the gene GPT and COVID-19.